143 related articles for article (PubMed ID: 16680034)
1. Genetics of familial combined hyperlipidemia.
Naukkarinen J; Ehnholm C; Peltonen L
Curr Opin Lipidol; 2006 Jun; 17(3):285-90. PubMed ID: 16680034
[TBL] [Abstract][Full Text] [Related]
2. Familial combined hyperlipidemia: upstream transcription factor 1 and beyond.
Lee JC; Lusis AJ; Pajukanta P
Curr Opin Lipidol; 2006 Apr; 17(2):101-9. PubMed ID: 16531745
[TBL] [Abstract][Full Text] [Related]
3. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1).
Pajukanta P; Lilja HE; Sinsheimer JS; Cantor RM; Lusis AJ; Gentile M; Duan XJ; Soro-Paavonen A; Naukkarinen J; Saarela J; Laakso M; Ehnholm C; Taskinen MR; Peltonen L
Nat Genet; 2004 Apr; 36(4):371-6. PubMed ID: 14991056
[TBL] [Abstract][Full Text] [Related]
4. Familial combined hyperlipidemia in Mexicans: association with upstream transcription factor 1 and linkage on chromosome 16q24.1.
Huertas-Vazquez A; Aguilar-Salinas C; Lusis AJ; Cantor RM; Canizales-Quinteros S; Lee JC; Mariana-Nuñez L; Riba-Ramirez RM; Jokiaho A; Tusie-Luna T; Pajukanta P
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1985-91. PubMed ID: 15976322
[TBL] [Abstract][Full Text] [Related]
5. Unraveling the complex genetics of familial combined hyperlipidemia.
Suviolahti E; Lilja HE; Pajukanta P
Ann Med; 2006; 38(5):337-51. PubMed ID: 16938803
[TBL] [Abstract][Full Text] [Related]
6. Potential role of upstream stimulatory factor 1 gene variant in familial combined hyperlipidemia and related disorders.
Auer S; Hahne P; Soyal SM; Felder T; Miller K; Paulmichl M; Krempler F; Oberkofler H; Patsch W
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1535-44. PubMed ID: 22460558
[TBL] [Abstract][Full Text] [Related]
7. Functional variant disrupts insulin induction of USF1: mechanism for USF1-associated dyslipidemias.
Naukkarinen J; Nilsson E; Koistinen HA; Söderlund S; Lyssenko V; Vaag A; Poulsen P; Groop L; Taskinen MR; Peltonen L
Circ Cardiovasc Genet; 2009 Oct; 2(5):522-9. PubMed ID: 20031629
[TBL] [Abstract][Full Text] [Related]
8. USF1 and dyslipidemias: converging evidence for a functional intronic variant.
Naukkarinen J; Gentile M; Soro-Paavonen A; Saarela J; Koistinen HA; Pajukanta P; Taskinen MR; Peltonen L
Hum Mol Genet; 2005 Sep; 14(17):2595-605. PubMed ID: 16076849
[TBL] [Abstract][Full Text] [Related]
9. Contribution of chromosome 1q21-q23 to familial combined hyperlipidemia in Mexican families.
Huertas-Vázquez A; del Rincón JP; Canizales-Quinteros S; Riba L; Vega-Hernández G; Ramírez-Jiménez S; Aurón-Gómez M; Gómez-Pérez FJ; Aguilar-Salinas CA; Tusié-Luna MT
Ann Hum Genet; 2004 Sep; 68(Pt 5):419-27. PubMed ID: 15469419
[TBL] [Abstract][Full Text] [Related]
10. USF1 implicated in the aetiology of familial combined hyperlipidaemia and the metabolic syndrome.
Shoulders CC; Naoumova RP
Trends Mol Med; 2004 Aug; 10(8):362-5. PubMed ID: 15310455
[TBL] [Abstract][Full Text] [Related]
11. Association of USF1 and APOA5 polymorphisms with familial combined hyperlipidemia in an Italian population.
Di Taranto MD; Staiano A; D'Agostino MN; D'Angelo A; Bloise E; Morgante A; Marotta G; Gentile M; Rubba P; Fortunato G
Mol Cell Probes; 2015 Feb; 29(1):19-24. PubMed ID: 25308402
[TBL] [Abstract][Full Text] [Related]
12. Genetic dissection of familial combined hyperlipidemia.
Eurlings PM; van der Kallen CJ; Geurts JM; van Greevenbroek MM; de Bruin TW
Mol Genet Metab; 2001; 74(1-2):98-104. PubMed ID: 11592807
[TBL] [Abstract][Full Text] [Related]
13. [Fifty years studying hiperlipidemias: the case of familial combined hyperlipidemia].
Aguilar-Salinas C; Gómez-Díaz R; Tusié-Luna MT
Invest Clin; 2010 Jun; 51(2):145-58. PubMed ID: 20928976
[TBL] [Abstract][Full Text] [Related]
14. A systems genetics approach implicates USF1, FADS3, and other causal candidate genes for familial combined hyperlipidemia.
Plaisier CL; Horvath S; Huertas-Vazquez A; Cruz-Bautista I; Herrera MF; Tusie-Luna T; Aguilar-Salinas C; Pajukanta P
PLoS Genet; 2009 Sep; 5(9):e1000642. PubMed ID: 19750004
[TBL] [Abstract][Full Text] [Related]
15. Familial combined hyperlipidemia: controversial aspects of its diagnosis and pathogenesis.
Aguilar Salinas CA; Zamora M; Gómez-Díaz RA; Mehta R; Gómez Pérez FJ; Rull JA
Semin Vasc Med; 2004 May; 4(2):203-9. PubMed ID: 15478042
[TBL] [Abstract][Full Text] [Related]
16. [Familial combined hyperlipidemia].
Sasaki J
Nihon Rinsho; 1999 Dec; 57(12):2776-81. PubMed ID: 10638212
[TBL] [Abstract][Full Text] [Related]
17. Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia.
Eichenbaum-Voline S; Olivier M; Jones EL; Naoumova RP; Jones B; Gau B; Patel HN; Seed M; Betteridge DJ; Galton DJ; Rubin EM; Scott J; Shoulders CC; Pennacchio LA
Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):167-74. PubMed ID: 14551155
[TBL] [Abstract][Full Text] [Related]
18. Variants in the PPARgamma gene affect fatty acid and glycerol metabolism in familial combined hyperlipidemia.
Eurlings PM; van der Kallen CJ; Vermeulen VM; de Bruin TW
Mol Genet Metab; 2003 Nov; 80(3):296-301. PubMed ID: 14680975
[TBL] [Abstract][Full Text] [Related]
19. Genetics of familial combined hyperlipidemia and risk of coronary heart disease.
Shoulders CC; Jones EL; Naoumova RP
Hum Mol Genet; 2004 Apr; 13 Spec No 1():R149-60. PubMed ID: 14764618
[TBL] [Abstract][Full Text] [Related]
20. Associations between USF1 gene variants and cardiovascular risk factors in the Quebec Family Study.
Choquette AC; Bouchard L; Houde A; Bouchard C; Pérusse L; Vohl MC
Clin Genet; 2007 Mar; 71(3):245-53. PubMed ID: 17309647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
